JPS4969648A - - Google Patents

Info

Publication number
JPS4969648A
JPS4969648A JP48105836A JP10583673A JPS4969648A JP S4969648 A JPS4969648 A JP S4969648A JP 48105836 A JP48105836 A JP 48105836A JP 10583673 A JP10583673 A JP 10583673A JP S4969648 A JPS4969648 A JP S4969648A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48105836A
Other languages
Japanese (ja)
Other versions
JPS5327263B2 (sv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4969648A publication Critical patent/JPS4969648A/ja
Publication of JPS5327263B2 publication Critical patent/JPS5327263B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP10583673A 1972-09-18 1973-09-18 Expired JPS5327263B2 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4315072 1972-09-18
GB998773*[A GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives
GB998873 1973-03-01
GB1030373 1973-03-02

Publications (2)

Publication Number Publication Date
JPS4969648A true JPS4969648A (sv) 1974-07-05
JPS5327263B2 JPS5327263B2 (sv) 1978-08-07

Family

ID=27447738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10583673A Expired JPS5327263B2 (sv) 1972-09-18 1973-09-18

Country Status (13)

Country Link
JP (1) JPS5327263B2 (sv)
AR (4) AR206505A1 (sv)
CA (1) CA992547A (sv)
CH (1) CH585690A5 (sv)
DD (2) DD109802A5 (sv)
ES (3) ES418827A1 (sv)
FR (1) FR2199988B1 (sv)
GB (1) GB1405444A (sv)
HU (1) HU168018B (sv)
IL (1) IL43218A (sv)
LU (1) LU68426A1 (sv)
MX (1) MX3233E (sv)
NL (1) NL152246B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975461A (en) * 1986-06-19 1990-12-04 E. R. Squibb & Sons, Inc. P-aminophenols, derivatives thereof and method of use
JPH0293610U (sv) * 1989-01-09 1990-07-25
ATE335482T1 (de) * 1999-06-10 2006-09-15 Bridge Pharma Inc Dermale anästhetika
EP1658847A3 (en) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
HUP0104841A3 (en) 1999-09-17 2002-07-29 Daiichi Suntory Pharma Co Ltd Medicaments containing benzoquinone- or condensed pyrimidine derivatives as active ingredient for treating of myocarditis, dilated cardiomyopathy and cardiac insufficiency
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds

Also Published As

Publication number Publication date
FR2199988B1 (sv) 1977-11-25
AR205891A1 (es) 1976-06-15
DD109802A5 (sv) 1974-11-20
AR206505A1 (es) 1976-07-30
GB1405444A (en) 1975-09-10
IL43218A (en) 1977-05-31
ES440029A1 (es) 1977-02-16
IL43218A0 (en) 1973-11-28
DE2346337A1 (de) 1974-04-04
HU168018B (sv) 1976-02-28
ES418827A1 (es) 1977-02-01
NL152246B (nl) 1977-02-15
JPS5327263B2 (sv) 1978-08-07
AR204247A1 (es) 1975-12-10
AU6028373A (en) 1975-03-13
MX3233E (es) 1980-08-05
CA992547A (en) 1976-07-06
CH585690A5 (sv) 1977-03-15
NL7312776A (sv) 1974-03-20
DE2346337B2 (de) 1976-08-26
FR2199988A1 (sv) 1974-04-19
AR203500A1 (es) 1975-09-15
LU68426A1 (sv) 1973-11-26
DD108277A5 (sv) 1974-09-12
ES440030A1 (es) 1977-02-16

Similar Documents

Publication Publication Date Title
FR2199988B1 (sv)
JPS4925073A (sv)
BG18106A1 (sv)
BG18386A1 (sv)
BG18499A1 (sv)
BG19428A1 (sv)
BG22072A3 (sv)
CH1668773A4 (sv)
CH1809873A4 (sv)
CH322372A4 (sv)
CH555674A4 (sv)
CH557907A (sv)
CH561428A5 (sv)
CH561786A5 (sv)
CH563097A5 (sv)
CH565978A5 (sv)
CH566825A (sv)
CH569167A5 (sv)
CH570064A5 (sv)
CH572102A5 (sv)
CH572363A5 (sv)
CH572682A5 (sv)
CH574146A5 (sv)
CH574595A5 (sv)
CH574911A5 (sv)